REQUEST A DEMO
Total
USD $0.00
Search more companies

Tchaikapharma High Quality Medicines AD (Bulgaria)

Main Activities: Pharmaceutical Preparation Manufacturing | Drugs and Druggists' Sundries Merchant Wholesalers
Full name: Tchaikapharma High Quality Medicines AD Profile Updated: October 31, 2024
Buy our report for this company USD 29.95 Most recent financial data: 2023 Available in: English Download a sample report

Tchaikapharma High Quality Medicines AD is a rapidly growing pharmaceutical manufacturer in Bulgaria. The company's focus is on providing accessible modern therapeutic solutions in the country, the region, and the European market, in accordance with the highest standards of Good Manufacturing Practice (GMP). The company's talent for fast market penetration is evidenced by the results we have achieved and continue to achieve on behalf of our partners. Our success is built on genuine respect for patients and our long-standing relationship with specialists. In line with the company's strategic goals of transparency and growth, Tchaikapharma became a public company on May 21, 2015. Since then, the company's shares have been successfully traded on the Bulgarian Stock Exchange.

Headquarters
1 G.M.Dimitrov Blvd.
Sofia; Sofia - city; Postal Code: 1172

Contact Details: Purchase the Tchaikapharma High Quality Medicines AD report to view the information.

Website: http://www.tchaikapharma.com

Basic Information
Total Employees:
Purchase the Tchaikapharma High Quality Medicines AD report to view the information.
Outstanding Shares:
Purchase the Tchaikapharma High Quality Medicines AD report to view the information.
Registered Capital:
Purchase the Tchaikapharma High Quality Medicines AD report to view the information.
Financial Auditors:
Purchase the Tchaikapharma High Quality Medicines AD report to view the information.
Incorporation Date:
March 14, 2000
Key Executives
Purchase this report to view the information.
Chairman
Purchase this report to view the information.
Member of the Management Board
Purchase this report to view the information.
Member of the Management Board
Purchase this report to view the information.
Investor Relations
Ownership Details
Purchase this report to view the information.
88.09%
Purchase this report to view the information.
6.86%
Subsidiaries
Swissy S. R. L. Romania (Romania)
100%
Perpetel Ead
Company Performance
Financial values in the chart are available after Tchaikapharma High Quality Medicines AD report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency BGN. Absolute financial data is included in the purchased report.
Net sales revenue
3.79%
Total operating revenue
4.04%
Operating profit (EBIT)
-27.36%
EBITDA
-25.63%
Net Profit (Loss) for the Period
-34.45%
Total assets
2.18%
Total equity
1.83%
Operating Profit Margin (ROS)
-5.76%
Net Profit Margin
-6.12%
Return on Equity (ROE)
-1.44%
Debt to Equity Ratio
-0.85%
Quick Ratio
-0.27%
Cash Ratio
-0%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?